Live Quote · NASDAQIKTHealthcare· Biotechnology

Inhibikase Therapeutics, Inc.

$1.32▲ 1.54%(+$0.02)
MKT CAP $185.16MNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
57/100
▌ Mixed
90
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IKT research report →

Analyst Price Target
$4.83+265.9% vs. today

Range $1.5 – $8

Analyst RatingHold
1 Buy2 Hold0 Sell

Price Chart

-13.73% · this period
$2.52$1.91$1.30Nov 20May 26Nov 20
52-Week Range3% of range
Low
$1.28
Current
$1.32
High
$2.61